ESOPHAGUS: Edited by Stuart J. SpechlerHow to choose among fundoplication, magnetic sphincter augmentation or transoral incisionless fundoplicationRabach, Lauren; Saad, Adham R.; Velanovich, VicAuthor Information Division of General Surgery, University of South Florida, Tampa, Florida, USA Correspondence to Vic Velanovich, Division of General Surgery, University of South Florida, 5 Tampa General Circle, Suite 740, Tampa, FL 33707, USA. Tel: +1 813 844 4005; fax: +1 813 844 1920; e-mail: email@example.com Current Opinion in Gastroenterology: July 2019 - Volume 35 - Issue 4 - p 371-378 doi: 10.1097/MOG.0000000000000550 Buy Metrics Abstract Purpose of review To examine current trends and research in nonmedical approaches to the treatment of gastroesophageal reflux disease (GERD). Recent findings Long-term studies of GERD patients treated with transoral incisionless fundoplication (TIF) have found that a large portion of patients resume proton pump inhibitor therapy. In patients with uncomplicated GERD, magnetic sphincter augmentation (MSA) shows excellent short-term results in both patient satisfaction and physiologic measures of GERD, with fewer postoperative side-effects than fundoplication, although dysphagia can be problematic. Summary Fundoplication remains the standard of care for patients with GERD complicated by hiatal hernias more than 2 cm, Barrett's esophagus and/or grade C and D erosive esophagitis. For the patient with uncomplicated GERD, MSA appears to be a viable alternative that has greater technical standardization and fewer postoperative side-effects than fundoplication. TIF remains an option for patients with refractory GERD who refuse surgical intervention. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.